- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03260075
Effects of Ward Cats in Patients With Substance Abuse, Depression and Psychosis at UPK Basel
November 5, 2018 updated by: Swiss Tropical & Public Health Institute
Effects of the Presence of Ward Cats on Patient Satisfaction and Ward Atmosphere for Patients With Substance Abuse, Depression and Psychosis at UPK Basel
The aim of this study is to explore the relationship between ward cats and patient satisfaction and stations atmosphere in patients with substance abuse, depression and psychosis.
Moreover, we wanted to investigate the patients perception of the ward cats and the relationship between station atmosphere perceived by the employees working wards with and without cat at UKP Basel.
Study Overview
Detailed Description
The following tools were used to address these aims:
- Available MüPF data regarding patient satisfaction of 170 inpatients during 2016 was analyzed.
- Available MüPF data regarding patient satisfaction of 151 inpatients during 2017 was analyzed.
- 33 patients were interviewed regarding their perception of the cats
- 30 staff members at the wards filled in questionnaires regarding station atmosphere (EssenCES)
Study Type
Observational
Enrollment (Actual)
388
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Basel, Switzerland, 4002
- Universitäre Psychiatrische Kliniken Basel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Inpatients at UPK Basel diagnosed with substance abuse, depression and psychosis as well as staff members working at these wards.
Description
Inclusion Criteria:
- Inpatient of the 7 wards at UPK Basel diagnosed with substance abuse, depression and psychosis
- staff working at these wards
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
ward cat
Patients and staff at wards that have a cat present
|
Cat living at the ward
|
|
no ward cat
Patients and staff at wards that have no cat present
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction (MüPF)
Time Frame: August - Sept 2017
|
Questionnaire MüPF 27
|
August - Sept 2017
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
station atmosphere
Time Frame: August - Sept 2017
|
Questionnaire EssenCES filled out by staff members
|
August - Sept 2017
|
|
Patient satisfaction (interview)
Time Frame: August - Sept 2017
|
Patients ratings of satisfaction is assessed in a semi-structured interview
|
August - Sept 2017
|
|
Patients perception of cats
Time Frame: August - Sept 2017
|
Patients perception of cats is assessed in a semi-structured interview
|
August - Sept 2017
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Karin Hediger, Dr., University of Basel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2017
Primary Completion (Actual)
December 15, 2017
Study Completion (Actual)
December 15, 2017
Study Registration Dates
First Submitted
August 21, 2017
First Submitted That Met QC Criteria
August 21, 2017
First Posted (Actual)
August 24, 2017
Study Record Updates
Last Update Posted (Actual)
November 7, 2018
Last Update Submitted That Met QC Criteria
November 5, 2018
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-00540
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Satisfaction
-
Duke UniversityCompletedPatient Satisfaction | Clinician SatisfactionUnited States
-
Shaukat Khanum Memorial Cancer Hospital & Research...CompletedSatisfaction, Patient | SatisfactionPakistan
-
Fu Jen Catholic UniversityRecruitingSatisfaction, PersonalTaiwan
-
Necmettin Erbakan UniversityGazi UniversityCompletedSatisfaction, Personal | KnowledgeTurkey (Türkiye)
-
Necmettin Erbakan UniversityCompletedSatisfaction | Waste ManagementTurkey (Türkiye)
-
University Hospital, BordeauxNot yet recruitingPregnancy | Telemedicine | Anesthesia | SatisfactionFrance
-
Nanne KleefstraCompletedPatient Satisfaction | Doctor Satisfaction | Duration of ConsultationNetherlands
-
Ernesto LosavioItem OxygenNot yet recruitingSatisfaction | Usability | Acceptability | User Experience
-
Pamukkale UniversityCompletedFlexibility | Life Satisfaction | Body AwarenessTurkey (Türkiye)
-
Yeditepe UniversityAl-Azhar University - GazaCompletedAmputation | Prosthesis User | Satisfaction | Quality of LiftePalestinian Territories
Clinical Trials on cat
-
Aier School of Ophthalmology, Central South UniversityUnknown
-
National Institute of Allergy and Infectious Diseases...Circassia LimitedCompletedCat Allergy | Cat HypersensitivityCanada
-
MedImmune LLCAstraZeneca; MedImmune LtdCompleted
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)TerminatedAsthma AtopicUnited States
-
Massachusetts General HospitalCompletedHand SurgeryUnited States
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Poland
-
Circassia LimitedCetero Research, San Antonio; Adiga Life Sciences, Inc.Completed
-
University Hospital, GrenobleActive, not recruitingAnorexia NervosaFrance
-
Medical University of South CarolinaCompletedAnxiety | Autism Spectrum Disorder | AutismUnited States
-
Boston Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...WithdrawnDiabetes Mellitus, Type 2United States